What is the recommended dosage and administration of Magnesium Sulfate (MgSO4) in the treatment of preeclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Magnesium Sulfate Dosage and Administration in Preeclampsia

The recommended dosage of magnesium sulfate for preeclampsia is a loading dose of 4-5g IV over 15-20 minutes, followed by a maintenance dose of 1-2g/hour by continuous IV infusion for 24 hours postpartum. 1

Intravenous Administration Protocol

Loading Dose

  • 4-5g IV in 250mL of 5% Dextrose or 0.9% Sodium Chloride over 15-20 minutes 1, 2

Maintenance Dose

  • 1-2g/hour by continuous IV infusion 1
  • Higher maintenance doses (2g/hour) may be required for overweight patients (BMI ≥25 kg/m²) 1
  • Continue for 24 hours postpartum 1

Alternative Intramuscular Protocol

When IV administration is not feasible:

  • Loading dose: 4g IV followed immediately by 5g IM in each buttock (total 14g loading) 3
  • Maintenance dose: 5g IM every 4 hours in alternate buttocks 2

Monitoring Requirements

Clinical Monitoring

  • Deep tendon reflexes (first sign of toxicity is loss of patellar reflex at 3.5-5 mmol/L) 1, 4
  • Respiratory rate (respiratory depression occurs at 5-6.5 mmol/L) 4
  • Urine output (should be >30mL/hour) 1
  • Level of consciousness 1

Laboratory Monitoring

  • Serum magnesium levels (target: 1.8-3.0 mmol/L for therapeutic effect) 4
  • Renal function (creatinine) 1
  • Liver function tests 1
  • Complete blood count (platelets, hemoglobin) 1

Special Considerations

Fluid Management

  • Restrict total fluid intake to 60-80 mL/hour during labor 1
  • Aim for euvolemia by replacing insensible losses (30 mL/hour) plus urinary losses (0.5-1 mL/kg/hour) 1
  • Avoid fluid overload as preeclamptic women are at risk of pulmonary edema due to capillary leak 1

Dose Adjustments

  • In severe renal insufficiency, maximum dosage should not exceed 20g/48 hours with frequent serum magnesium monitoring 2
  • Total daily dose should not exceed 30-40g in 24 hours 2

Duration Limitations

  • Continuous use beyond 5-7 days can cause fetal abnormalities 1, 2

Efficacy and Safety Considerations

  • Recent research suggests that shorter maintenance regimens (12-hour) may be as effective as the standard 24-hour regimen with fewer side effects 5
  • Some studies indicate that a single loading dose without maintenance may be sufficient in certain cases of severe preeclampsia 6
  • Clinical monitoring is generally sufficient; serum monitoring is not always necessary if clinical parameters are closely followed 7

Common Pitfalls and Caveats

  1. Inadequate duration: Discontinuing MgSO₄ too early can increase risk of eclampsia, as seizures can still occur after delivery 1

  2. Overdosage: Signs of magnesium toxicity progress from:

    • Loss of patellar reflex (3.5-5 mmol/L)
    • Respiratory depression (5-6.5 mmol/L)
    • Altered cardiac conduction (>7.5 mmol/L)
    • Cardiac arrest (>12.5 mmol/L) 4
  3. Underdosage: Particularly in overweight patients who may require higher maintenance doses 1

  4. Failure to adjust for renal impairment: Magnesium is primarily excreted by the kidneys, so dosage must be reduced in renal insufficiency 2

  5. Inadequate monitoring: Clinical monitoring of reflexes, respiration, and urine output is essential even when serum levels aren't measured 7

The evidence strongly supports the use of magnesium sulfate as the drug of choice for seizure prophylaxis in preeclampsia, with careful attention to dosing, administration, and monitoring to ensure both efficacy and safety.

References

Guideline

Magnesium Sulfate Therapy for Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous magnesium sulfate in the management of severe pre-eclampsia: A randomized study of 12-hour versus 24-hour maintenance dose.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2020

Research

Is magnesium sulfate for prevention or only therapeutic in preeclampsia?

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.